References
- Karia P, Han J, Schmults C. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol. 2013;68(6):957–966.
- Lee CB, Roorda BM, Wakkee M, et al. Recurrence rates of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery vs. standard excision: a retrospective cohort study. Br J Dermatol. 2019;181(2):338–343.
- Rowe D, Carroll R, Day C. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976–990.
- Jung G, Metelitsa A, Dover D, et al. Trends in incidence of nonmelanoma skin cancers in Alberta, Canada, 1988–2007. Br J Dermatol. 2010;163(1):146–154.
- Youl P, Janda M, Aitken J, et al. Body-site distribution of skin cancer, pre-malignant and common benign pigmented lesions excised in general practice. Br J Dermatol. 2011;165(1):35–43.
- Nahhas A, Scarbrough C, Trotter S. A review of the global guidelines on surgical margins for nonmelanoma skin cancers. J Clin Aesthet Dermatol. 2017;10(4):37–46.
- Brodland D, Zitelli J. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1992;27(2):241–248.
- Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol. 2002;146(1):18–25.
- Stratigos A, Garbe C, Lebbe C, et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer. 2015;51(14):1989–2007.
- Cancer Council Austrailia, Clinical practice guidelines for keratinocyte cancer, https://www.wiki.cancer.org.au/australia. 2021; [cited 2021 Mar 20]. Available from: https://wiki.cancer.org.au/australia/Guidelines:Keratinocyte_carcinoma.
- Keohane S, Botting J, Budny P, et al. British association of dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020. Br J Dermatol. 2021;184(3):401–414.
- SIGN. Scottish Intercollegiate Guidelines Network, Management of primary cutaneous squamous cell carcinoma, 2014; [cited 2021 Mar 13]. Available from: https://www.sign.ac.uk/media/1094/sign140.pdf.
- The jamovi project 2021. jamovi (Version 1.6) [Computer Software]. Retrieved from https://www.jamovi.org. [computer program]. 2020.
- Brierley J, Gospodarowicz M, Wittekind C. TNM classification of malignant tumours. 8th ed. New York: Union for International Cancer Control; 2016.
- Jenkins G, Smith A, Kanatas A, et al. Anatomical restrictions in the surgical excision of scalp squamous cell carcinomas: does this affect local recurrence and regional nodal metastases? Int J Oral Maxillofac Surg. 2014;43(2):142–146.
- Khan K, Mykula R, Kerstein R, et al. A 5-year follow-up study of 633 cutaneous SCC excisions: rates of local recurrence and lymph node metastasis. J Plast Reconstr Aesthet Surg. 2018;71(8):1153–1158.
- Mo J, Miller C, Karakousis G, et al. The scalp is a high-risk site for cutaneous squamous cell carcinoma metastasis. J Am Acad Dermatol. 2021;84(6):1742–1744.